CTOs on the Move

Luca Technologies

www.lucatechnologies.com

 
Luca Technologies, Inc. engages in the development of long-term biotechnology-driven solutions to the natural gas market in the United States.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

CAMH Centre for Addiction and Mental Health

CAMH Centre for Addiction and Mental Health is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. CAMH Centre for Addiction and Mental Health is based in Toronto, ON. You can find more information on CAMH Centre for Addiction and Mental Health at www.camh.net

KeyMedical Software

KeyMedical Software is a Lebanon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shaw Science Partners

Shaw Science Partners is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.